Skip to Content
Merck
  • Dynamics of sphingolipids and the serine palmitoyltransferase complex in rat oligodendrocytes during myelination.

Dynamics of sphingolipids and the serine palmitoyltransferase complex in rat oligodendrocytes during myelination.

Journal of lipid research (2020-02-12)
Deanna L Davis, Usha Mahawar, Victoria S Pope, Jeremy Allegood, Carmen Sato-Bigbee, Binks W Wattenberg
ABSTRACT

Myelin is a unique lipid-rich membrane structure that accelerates neurotransmission and supports neuronal function. Sphingolipids are critical myelin components. Yet sphingolipid content and synthesis have not been well characterized in oligodendrocytes, the myelin-producing cells of the CNS. Here, using quantitative real-time PCR, LC-MS/MS-based lipid analysis, and biochemical assays, we examined sphingolipid synthesis during the peak period of myelination in the postnatal rat brain. Importantly, we characterized sphingolipid production in isolated oligodendrocytes. We analyzed sphingolipid distribution and levels of critical enzymes and regulators in the sphingolipid biosynthetic pathway, with focus on the serine palmitoyltransferase (SPT) complex, the rate-limiting step in this pathway. During myelination, levels of the major SPT subunits increased and oligodendrocyte maturation was accompanied by extensive alterations in the composition of the SPT complex. These included changes in the relative levels of two alternative catalytic subunits, SPTLC2 and -3, in the relative levels of isoforms of the small subunits, ssSPTa and -b, and in the isoform distribution of the SPT regulators, the ORMDLs. Myelination progression was accompanied by distinct changes in both the nature of the sphingoid backbone and the N-acyl chains incorporated into sphingolipids. We conclude that the distribution of these changes among sphingolipid family members is indicative of a selective channeling of the ceramide backbone toward specific downstream metabolic pathways during myelination. Our findings provide insights into myelin production in oligodendrocytes and suggest how dysregulation of the biosynthesis of this highly specialized membrane could contribute to demyelinating diseases.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-SPTLC2 Antibody, serum, from rabbit
Sigma-Aldrich
Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody, clone 8-18C5, Chemicon®, from mouse
Sigma-Aldrich
Myriocin from Mycelia sterilia, ≥98% (HPLC), powder
Sigma-Aldrich
Papain from papaya latex, lyophilized powder, ≥10 units/mg protein
Sigma-Aldrich
Chloroform – isoamyl alcohol mixture, BioUltra, for molecular biology, 49:1, ≥99.5% (chloroform + isoamyl alcohol, GC)
Sigma-Aldrich
Deoxyribonuclease I from bovine pancreas, lyophilized powder, Protein ≥85 %, ≥400 Kunitz units/mg protein
Sigma-Aldrich
Anti-Myelin Basic Protein Antibody, a.a. 82-87, culture supernatant, clone 12, Chemicon®
Sigma-Aldrich
Anti-Myelin Associated Glycoprotein Antibody, clone 513, clone 513, Chemicon®, from mouse